Market Tracker

06/24 5:16pm ET

Clovis Oncology Inc (NASDAQ:CLVS)

13.01
Delayed Data
As of Jun 24
 -0.92 / -6.60%
Today’s Change
11.58
Today|||52-Week Range
116.75
-62.83%
Year-to-Date
5 Reasons to Hate Biotech Stocks
Jun 23 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close13.93
Today’s open13.23
Day’s range12.99 - 13.86
Volume972,019
Average volume (3 months)1,285,002
Market cap$534.7M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-107.42%
Earnings growth (this year)+17.63%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book1.78

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...-0.86-6.99%
PDLIPDL BioPharma Inc-0.07-2.23%
LOXOLoxo Oncology Inc-0.53-2.20%
ARRYArray Biopharma Inc-0.13-3.63%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$2.12
Annual revenue (last year)$0.00
Annual profit (last year)-$352.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
VP, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts